Literature DB >> 11903206

The collaborative practice model for bipolar disorder: design and implementation in a multi-site randomized controlled trial.

M S Bauer1.   

Abstract

Bipolar disorder remains a high morbidity and costly illness in general clinical practice, despite the availability of efficacious medications. This 'efficacy-effectiveness gap' may be addressed by better organizing systems of care. One type of intervention is the 'collaborative practice model' which can be defined as an organization of care that a) emphasizes development in the patient of illness management skills, and b) supports provider capability and availability in order to c) engage patients in timely, joint decision-making regarding their illness. This article describes such a collaborative practice model for bipolar disorder, designed to be widely adoptable and sustainable in general clinical practice. The first part of the article describes the theoretical background from which the collaborative practice approach developed, emphasizing its origins in the lithium clinics of the 1970s, in nursing theory and practice, and more recently in the management of chronic medical diseases. The second part describes the structure of one such intervention, the Bipolar Disorders Program (BDP) developed in the Veterans Affairs health care system. The third part summarizes results from single-site studies of the intervention. The fourth part describes several key issues in its implementation in an ongoing multi-site randomized controlled trial, VA Cooperative Study Program (CSP) # 430. Data to date indicate that such collaborative practice interventions may improve important process and intermediate outcome variables for bipolar disorder. The BDP provides an example of a multi-faceted collaborative practice model that can be manualized and implemented across multiple sites in a randomized controlled trial.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11903206     DOI: 10.1034/j.1399-5618.2001.30502.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  8 in total

1.  Enhancing medication adherence: in older adults with bipolar disorder.

Authors:  Colin A Depp; Barry D Lebowitz
Journal:  Psychiatry (Edgmont)       Date:  2007-06

2.  [Psychiatric care for subjects with bipolar disorder: results of the new German S3 guidelines].

Authors:  P Brieger; L Bode; R Urban; A Pfennig
Journal:  Nervenarzt       Date:  2012-05       Impact factor: 1.214

3.  Preventing mania: a preliminary examination of the GOALS Program.

Authors:  Sheri L Johnson; Daniel Fulford
Journal:  Behav Ther       Date:  2008-10-22

4.  Randomized controlled trial of a health plan-level mood disorders psychosocial intervention for solo or small practices.

Authors:  Amy M Kilbourne; Kristina M Nord; Julia Kyle; Celeste Van Poppelen; David E Goodrich; Hyungjin Myra Kim; Daniel Eisenberg; Hyong Un; Mark S Bauer
Journal:  BMC Psychol       Date:  2014-11-13

5.  Development of Coaching Support for LiveWell: A Smartphone-Based Self-Management Intervention for Bipolar Disorder.

Authors:  Cynthia A Dopke; Alyssa McBride; Pamela Babington; Geneva K Jonathan; Tania Michaels; Chloe Ryan; Jennifer Duffecy; David C Mohr; Evan H Goulding
Journal:  JMIR Form Res       Date:  2021-03-24

Review 6.  Psychosocial interventions and medication adherence in bipolar disorder.

Authors:  Colin A Depp; David J Moore; Thomas L Patterson; Barry D Lebowitz; Dilip V Jeste
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

7.  The prevalence and significance of substance use disorders in bipolar type I and II disorder.

Authors:  Michael A Cerullo; Stephen M Strakowski
Journal:  Subst Abuse Treat Prev Policy       Date:  2007-10-01

8.  Treatment of bipolar disorder in the Netherlands and concordance with treatment guidelines: study protocol of an observational, longitudinal study on naturalistic treatment of bipolar disorder in everyday clinical practice.

Authors:  Joannes W Renes; Eline J Regeer; Trijntje Y G van der Voort; Willem A Nolen; Ralph W Kupka
Journal:  BMC Psychiatry       Date:  2014-02-28       Impact factor: 3.630

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.